(budesonide/glycopyrrolate/formoterol fumarate) Now Approved. Visit The Physician Site. Explore A New Approved Treatment Option. Be The First To Learn About BREZTRI. Now Approved. Prescribing Information. Register For Updates. Learn The Pronunciation.
Learn More About VEKLURY® as an FDA Approved Treatment Option for Eligible Patients. Product Access Information and Resources for HCPs are Available Here. Product Access. Register for Updates. Dosing & Administration. HCP Resources. Patient Support for HCPs.
Helpful information for your patients. Get product information intended for healthcare professionals. Resources. About KALYDECO. Studies and Data.
Visit The Official HCP Website for GAVRETO Information. Learn More Today. Safety Information. Registration Form. Patient Services. HCP Information. Patient Support. Dosing Information. Downloadable Resources. Healthcare Professionals. Prescribing Information.
Learn about an FDA-approved continued treatment option for patients with AML in remission. Register to receive updates. See safety info & full Prescribing Info.
To Learn More, Visit XARACOLL.com · A portfolio company of. Gurent Point Capital. Innocoll Logo. Business Development Group Unit 9, Block D Monksland ...
TEPEZZA is a prescription medicine for the treatment of Thyroid Eye Disease (TED), also known as Graves' Orbitopathy. See safety information.
KESIMPTA® is FDA Approved. Download a Start Form Today. Visit Now to Learn More. Access PI and Start Resources for HCPs. Contact Us for Support. Enrollment Support. Official HCP Website. HCP Resources. FDA Approved. KESIMPTA® Safety Info.
Visit Official HCP Site to See if Evrysdi™ Could be an Option for Your Patients. Evrysdi Challenges. Evrysdi Education. Evrysdi Resources. Evrysdi Treatment. Types: Learn About Evrysdi, Clinical Trial Results, Safety and Efficacy, Potential Benefits.
CYSTADROPS (cysteamine ophthalmic solution) 0.37% is a cystine-depleting agent indicated for the treatment of corneal cystine crystal deposits in adults and children with cystinosis.
Explore ENSPRYNG™ As A New Treatment Option For Your Patients. Contraindications. Prescribing Information. Safety Info. Dosing & Admin. Types: Financial Assistance, ENSPRYNG Access Solutions, Clinical Trial Data, Patient Resources.
VILTEPSO is a treatment for Duchenne muscular dystrophy (DMD) in patients amenable to exon 53 skipping. Learn more about the clinical benefits.
Zokinvy (lonafarnib) now FDA approved for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS or Progeria) and processing-deficient Progeroid ...
For Rheumatologists and Nephrologists: See LUPKYNIS™ prescribing info and boxed warning. Learn more about this new FDA approved medication. Register for Updates · Contact a Rep · Prescribing Information
Learn About The TG Patient Support™️ Program To Help Your Patients Access UKONIQ™️. Find Out More About UKONIQ™️, An Exciting New Treatment Option For Your Patients. Prescribing Information. About UKONIQ™️. Professional Resources. TG PatientSupport™️.
Breyanzi® (lisocabtagene maraleucel) - See Boxed Warning, Full Safety & Prescribing Info. A New Treatment Option That May Help Your Patients. Get the Info You Need.
Attention Physicians - View Important Information On CABENUVA Injectable Suspensions. Educational Resources. Clinical Trial Results. Types: Official HCP Site, Prescribing Info.
HCPs - Now Approved - EVKEEZA™ (evinacumab-dgnb)
Visit the Site to Register and Receive the Info You Need For This Once-Daily Treatment. Coming Soon: The Once-Daily Treatment PONVORY™. Sign Up For More Information! For HCPs. Coming Soon. Sign Up for More Info.
Discover why NULIBRY may be an option for your patients. Learn about NULIBRY Dosing. FDA-Approved. Find out more. Services: Patient Support Program, Patient Access Program, Dosing Guide.